无创呼吸机标准化治疗联合氨茶碱在慢阻肺并Ⅱ型呼衰中的应用OACHSSCD
Application of Non-invasive Ventilator Standardized Treatment Combined with Aminophylline in COPD Patients with Type Ⅱ Respiratory Failure
目的:探讨无创呼吸机标准化治疗联合氨茶碱应用于慢性阻塞性肺病(Chronic Obstructive Pulmonary Disease,COPD)合并II型呼吸衰竭患者中的临床效果.方法:选取甘肃省白银市中心医院于2023年6月至2024年6月间收治的80例COPD合并Ⅱ型呼衰患者作为研究对象,随机分为对照组和观察组,各40例.对照组采取基础治疗+氨茶碱,观察组采取基础治疗+氨茶碱+无创呼吸机标准化治疗.对比两组患者的肺功能、血气指标[氧分压(Partial pressure of oxygen,PaO2)和二氧化碳分压(Partial pressure of carbon dioxide,PaCO2)].结果:观察组患者的肺功能、PaO2高于对照组(P<0.05);观察组患者的PaCO2低于对照组(P<0.05).结论:无创呼吸机标准化治疗联合氨茶碱应用于COPD合并Ⅱ型呼衰中,能够改善肺通气功能,进而纠正血气指标异常.
Objective:To explore the clinical effect of non-invasive ventilator standardized treatment combined with aminophylline in patients with chronic obstructive pulmonary disease(COPD)complicated with type II respiratory failure.Methods:Eighty patients with COPD complicated with type II respiratory failure admitted to the Baiyin Central Hospital of Gansu Province from June 2023 to June 2024 were selected as the research objects and randomly divided into a control group and an observation group,with 40 cases in each group.The control group received basic treatment+aminophylline,while the observation group received basic treatment+aminophylline+non-invasive ventilator standardized treatment.The lung function and blood gas indicators—partial pressure of oxygen(PaO2)and partial pressure of carbon dioxide(PaCO2)—of the two groups of patients were compared.Results:The lung function and PaO2 of patients in the observation group were higher than those in the control group(P<0.05);The PaCO2 of patients in the observation group was lower than that in the control group(P<0.05).Conclusion:The application of non-invasive ventilator standardized treatment combined with aminophylline in COPD complicated with type II respiratory failure can improve pulmonary ventilation function and thereby correct abnormal blood gas indicators.
胡东平
甘肃省白银市中心医院
无创呼吸机标准化治疗氨茶碱慢性阻塞性肺病Ⅱ型呼吸衰竭
non-invasive ventilator standardized treatmentaminophyllinechronic obstructive pulmonary diseasetype II respiratory failure
《中国标准化》 2026 (6)
319-322,4
评论